论文部分内容阅读
本研究的目的旨在探讨浸润性膀胱癌的ｐ５３状态是否有助于选择患者接受保留膀胱的治疗。１１１例有肌层浸润（Ｔ２～３Ｎ０Ｍ０）的膀胱移行细胞癌患者接受甲氨喋呤、长春花碱、阿霉素和顺铂（ＭＶＡＣ）的辅助化疗。其中６０例患者（５４％）对ＭＶＡＣ呈完全性临床...
The purpose of this study was to investigate whether the p53 status of invasive bladder cancer is helpful in selecting patients for treatment of retained bladder. 111 cases of bladder transitional cell carcinoma with myometrial invasion (T2 ~ 3N0M0) received adjuvant chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin (MVAC). Of which 60 patients (54%) were M VAC was completely clinical ...